PureTech Health
PUREtech has developed a research and development engine that improves tolerability, enables oral administration and enhances efficacy of certain therapeutics with 6x the industry average of clinical success. This process helps unlock the potential of treatments for patients with a range of diseases including tumours, epilepsy and fibrosis, providing a clear pathway to better address patient needs and improving the lives of people around the globe.
Year established: 2005
Lead Researcher: Christopher Porter
Website: puretechhealth.com